# A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects

> **NCT01981681** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 47 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06263726
- **DRUG:** PF-06263726
- **DRUG:** PF-06263726
- **DRUG:** Placebo
- **DRUG:** PF-06263726
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01981681
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2014-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01981681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01981681, "A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01981681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*